Forest is building on a strong track record of commercial achievement to deliver important new medicines and strengthen our therapeutic franchises
Forest partners with biotech and pharmaceutical companies around the world to develop and bring promising new medicines to market
Joining Forest is an opportunity to become part of a forward-thinking community dedicated to helping improve patients' lives through medicine
About Actavis + Forest
On July 1, 2014, Actavis (NYSE:ACT) completed the acquisition of Forest Laboratories, creating one of the world’s fastest-growing specialty pharmaceutical companies with annual revenues of more than $15 billion anticipated for 2015. The combination creates a Company with size and scale, a balanced offering of strong brands and generics, a focus on strategic, lower-risk drug development and a generic DNA, focused on cost efficiency across the expanded organization.
Join one of the world’s fastest-growing specialty pharmaceutical companies. The combination of Actavis + Forest is creating exciting career opportunities across our now larger and stronger global company. As we continue integrating our recruiting processes and systems, you may view career opportunities at the
Forest career sites.